Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients

SummaryThe clinical significance of detecting supposed tumour cell-derived mRNA transcripts in blood using the polymerase chain reaction (PCR) remains unclear. We have used a fully quantitative 5′-nuclease RT-PCR assay to screen for the expression of cytokeratins (ck) 19 and 20 and guanylyl cyclase C (GCC) in the peripheral blood of 21 healthy controls and 27 colorectal cancer patients. Expression of cytokeratin 19 and 20 mRNA was detected in 30% and 100% of samples, respectively, taken from healthy volunteers. There was no apparent difference in ck19 and ck20 mRNA transcription levels between controls and patients, or between patients with different Dukes’ stages. While GCC mRNA was detected in only 1/21 control samples, it was expressed in approximately 80% of patients, although again there was no correlation between GCC levels and disease stage. Transcription levels of all three markers varied considerably between samples, even between samples taken from the same person at different times. We conclude that neither ck19 nor ck20 are reliable markers for the detection of colon epithelial cells in peripheral blood and that an evaluation of the usefulness of GCC awaits further longitudinal studies.

[1]  J. Galmiche,et al.  Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients , 1997, International journal of cancer.

[2]  M. Ogawa,et al.  Genetic diagnosis of lymph-node metastasis in colorectal cancer , 1995, The Lancet.

[3]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Burchill,et al.  Detection of colorectal cancer cells in peripheral blood by reverse‐transcriptase polymerase chain reaction for cytokeratin 20 , 1998, International journal of cancer.

[5]  R. Warren,et al.  Molecular cytogenetic analysis of cytokeratin 20‐labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients , 1997, Cancer.

[6]  J. McCall,et al.  Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[7]  S. T. Traweek,et al.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. , 1993, The American journal of pathology.

[8]  K. Pantel,et al.  Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Huben,et al.  Haematogenous dissemination of cells from human renal adenocarcinomas. , 1988, British Journal of Cancer.

[10]  R. Moll,et al.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. , 1992, The American journal of pathology.

[11]  J. Hugnot,et al.  Illegitimate (or ectopic) transcription proceeds through the usual promoters. , 1991, Biochemical and biophysical research communications.

[12]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[13]  S J Parkinson,et al.  Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Juhl,et al.  Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Kidson,et al.  An improved and combined reverse transcription-polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood. , 1997, Melanoma research.

[16]  C. V. D. van de Velde,et al.  Micrometastases and survival in stage II colorectal cancer. , 1998, The New England journal of medicine.

[17]  A. Morris,et al.  Detection of circulating tumour cells and nodal metastasis by reverse transcriptase‐polymerase chain reaction technique , 1997, The British journal of surgery.

[18]  J. Jorcano,et al.  Patterns of Expression and Organization of Cytokeratin Intermediate Filaments , 1985, Annals of the New York Academy of Sciences.

[19]  K. Mimori,et al.  Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. , 1995, Cancer research.

[20]  T. Allen-Mersh,et al.  Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. , 1996, Gut.

[21]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[22]  J. Palazzo,et al.  Use of guanylyl cyclase c for detecting micrometastases in lymph nodes of patients with colon cancer , 1998, Diseases of the colon and rectum.

[23]  D. Cooper,et al.  Ectopic (illegitimate) transcription: new possibilities for the analysis and diagnosis of human genetic disease. , 1994, Annals of medicine.

[24]  S. Bustin,et al.  Genetic detection of lymph node micrometastases in patients with colorectal cancer , 1998, The British journal of surgery.

[25]  G. Giaccone,et al.  Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[26]  J. Concordet,et al.  Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Leygue,et al.  Triple primer polymerase chain reaction. A new way to quantify truncated mRNA expression. , 1996, The American journal of pathology.

[28]  S. Burchill,et al.  The molecular detection of circulating tumour cells. , 1995, British Journal of Cancer.

[29]  S. Baylin,et al.  Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene. A new, sensitive approach to monitor tumor cells in acute myelogenous leukemia. , 1992, Leukemia research.

[30]  M. Imamura,et al.  Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. , 1997, Life sciences.

[31]  R J Salmon,et al.  [Prognostic factors of colorectal cancer]. , 1989, Pathologie-biologie.

[32]  A. Foss,et al.  The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. , 1995, British Journal of Cancer.

[33]  P. Wernet,et al.  Rapid and sensitive mRNA phenotyping for interleukins (IL-1 to IL-6) and colony-stimulating factors (G-CSF, M-CSF, and GM-CSF) by reverse transcription and subsequent polymerase chain reaction. , 1991, Experimental hematology.

[34]  D. Tarin,et al.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. , 1984, Cancer research.

[35]  S. Bustin,et al.  Molecular assessment of tumour stage and disease recurrence using PCR-based assays. , 1998, Molecular medicine today.

[36]  R. Moll,et al.  The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. , 1993, Differentiation; research in biological diversity.